$BEIGENE LTD SPON ADS EACH REP

$BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS(ONC)$ ’s Brukinsa raked in over $2 billion last year，way more than all of $Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276)$ ’s innovative drugs combined! The stock is pushing for new highs, and the hype around innovative drugs is getting real. This sector looks ready to take off, and BeiGene is leading the pack!

Winning Trades

Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":419779410780544,"tweetId":"419779410780544","gmtCreate":1743493003750,"gmtModify":1743493008639,"author":{"id":9000000000000456,"idStr":"9000000000000456","authorId":9000000000000456,"authorIdStr":"9000000000000456","name":"NewmanGray","avatar":"https://static.tigerbbs.com/bf65ca86aeb00567f8edf7489edd03ae","vip":8,"userType":8,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":false},"themes":[{"themeId":"7516f9ef7e8042739b8597466da26fe7","categoryId":"7cf744760f454845a1870a05ea4e151d","name":"Winning Trades","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":7516f9ef7e8042739b8597466da26fe7}&rnconfig={\"headerBarHidden\": true}","description":"Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.","image":"https://community-static.tradeup.com/news/14c89d9656aedb9a4698e7996c575947"}],"images":[{"img":"https://community-static.tradeup.com/news/a81a8435cdc1169a22723d81ec9c0d2b","width":"767","height":"1280"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/a81a8435cdc1169a22723d81ec9c0d2b","width":"767","height":"1280"}],"html":"<html><head></head><body> <a data-mention-id=\"ONC\" class=\"teditor-mention\" data-mention-name=\"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS\" href=\"https://ttm.financial/S/ONC\">$BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS(ONC)$</a> ’s Brukinsa raked in over $2 billion last year，way more than all of <a data-mention-id=\"600276\" class=\"teditor-mention\" data-mention-name=\"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.\" href=\"https://ttm.financial/S/600276\">$Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276)$</a> ’s innovative drugs combined! The stock is pushing for new highs, and the hype around innovative drugs is getting real. This sector looks ready to take off, and BeiGene is leading the pack!<img src=\"https://community-static.tradeup.com/news/a81a8435cdc1169a22723d81ec9c0d2b\" tg-width=\"767\" tg-height=\"1280\"></body></html>","htmlText":"<html><head></head><body> <a data-mention-id=\"ONC\" class=\"teditor-mention\" data-mention-name=\"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS\" href=\"https://ttm.financial/S/ONC\">$BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS(ONC)$</a> ’s Brukinsa raked in over $2 billion last year，way more than all of <a data-mention-id=\"600276\" class=\"teditor-mention\" data-mention-name=\"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.\" href=\"https://ttm.financial/S/600276\">$Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276)$</a> ’s innovative drugs combined! The stock is pushing for new highs, and the hype around innovative drugs is getting real. This sector looks ready to take off, and BeiGene is leading the pack!<img src=\"https://community-static.tradeup.com/news/a81a8435cdc1169a22723d81ec9c0d2b\" tg-width=\"767\" tg-height=\"1280\"></body></html>","text":"$BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS(ONC)$ ’s Brukinsa raked in over $2 billion last year，way more than all of $Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276)$ ’s innovative drugs combined! The stock is pushing for new highs, and the hype around innovative drugs is getting real. This sector looks ready to take off, and BeiGene is leading the pack!","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/419779410780544","repostId":0,"isVote":1,"tweetType":1,"viewCount":2179,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["ONC","600276"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":299,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/419779410780544"}